Surface expression of ROR1 across lymphoma cell lines identifies models for preclinical evaluation of ROR1-targeting antibody-drug conjugates.

Tarantelli C, Civanelli E, Spriano F, Risi G, Cascione L, Kaufmann G, Bertoni F

Open source

DOI
10.1080/10428194.2026.2724722
Published
2026 Sep 7
Container
Leukemia & lymphoma
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/10428194.2026.2724722,
  title = {Surface expression of ROR1 across lymphoma cell lines identifies models for preclinical evaluation of ROR1-targeting antibody-drug conjugates.},
  author = {Tarantelli C and Civanelli E and Spriano F and Risi G and Cascione L and Kaufmann G and Bertoni F},
  year = {2026},
  journal = {Leukemia \& lymphoma},
  doi = {10.1080/10428194.2026.2724722},
  url = {https://doi.org/10.1080/10428194.2026.2724722}
}

RIS

TY  - JOUR
TI  - Surface expression of ROR1 across lymphoma cell lines identifies models for preclinical evaluation of ROR1-targeting antibody-drug conjugates.
AU  - Tarantelli C
AU  - Civanelli E
AU  - Spriano F
AU  - Risi G
AU  - Cascione L
AU  - Kaufmann G
AU  - Bertoni F
PY  - 2026
JO  - Leukemia & lymphoma
DO  - 10.1080/10428194.2026.2724722
UR  - https://doi.org/10.1080/10428194.2026.2724722
ER  - 

APA

C, T., E, C., F, S., G, R., L, C., G, K., & F, B. (2026). Surface expression of ROR1 across lymphoma cell lines identifies models for preclinical evaluation of ROR1-targeting antibody-drug conjugates.. Leukemia & lymphoma. https://doi.org/10.1080/10428194.2026.2724722

Source records